These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25533141)

  • 1. Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies.
    Crespo C; Monleon A; Díaz W; Ríos M
    BMC Med Res Methodol; 2014 Dec; 14():139. PubMed ID: 25533141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of economic evaluation studies: data harmonisation and methodological issues.
    Bagepally BS; Chaikledkaew U; Chaiyakunapruk N; Attia J; Thakkinstian A
    BMC Health Serv Res; 2022 Feb; 22(1):202. PubMed ID: 35168619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the censored cost-effectiveness analysis using copula information.
    Fontaine C; Daurès JP; Landais P
    BMC Med Res Methodol; 2017 Feb; 17(1):27. PubMed ID: 28202010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incremental cost effectiveness of multifocal cataract surgery].
    Pagel N; Dick HB; Krummenauer F
    Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis.
    Ang M; Nguyen HV; Kiew SY; Chen S; Chee SP; Finkelstein E
    Br J Ophthalmol; 2015 Jul; 99(7):984-9. PubMed ID: 25573149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).
    Sanders-van Wijk S; van Asselt AD; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Vuillomenet A; Peter M; Pfisterer ME; Brunner-La Rocca HP;
    JACC Heart Fail; 2013 Feb; 1(1):64-71. PubMed ID: 24621800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of a pharmacotherapy follow-up for elderly nursing home residents in Spain.
    Jódar-Sánchez F; Martín JJ; López del Amo MP; García L; Araújo-Santos JM; Epstein D
    J Am Geriatr Soc; 2014 Jul; 62(7):1272-80. PubMed ID: 24891096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.
    Rozenbaum MH; Sanders EA; van Hoek AJ; Jansen AG; van der Ende A; van den Dobbelsteen G; Rodenburg GD; Hak E; Postma MJ
    BMJ; 2010 Jun; 340():c2509. PubMed ID: 20519267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of the effect of pregabalin versus usual care in the treatment of refractory neuropathic pain in routine medical practice in Spain.
    de Salas-Cansado M; Pérez C; Saldaña MT; Navarro A; Rejas J
    Pain Med; 2012 May; 13(5):699-710. PubMed ID: 22594706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
    Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
    BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
    Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
    Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating patient-centered outcomes in the analysis of cost-effectiveness: imaging strategies for renovascular hypertension.
    Carlos RC; Axelrod DA; Ellis JH; Abrahamse PH; Fendrick AM
    AJR Am J Roentgenol; 2003 Dec; 181(6):1653-61. PubMed ID: 14627591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
    Gafni A; Birch S
    Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Benefit-Risk Assessment Methods for Prospective Monitoring of Newly Marketed Drugs: A Simulation Study.
    Gagne JJ; Najafzadeh M; Choudhry NK; Bykov K; Kahler KH; Martin D; Rogers JR; Schneeweiss S
    Value Health; 2015 Dec; 18(8):1057-62. PubMed ID: 26686791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric statistical methods for cost-effectiveness analyses.
    Dinh P; Zhou XH
    Biometrics; 2006 Jun; 62(2):576-88. PubMed ID: 16918923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation.
    Sánchez-Ortega I; Patiño B; Muñoz C; Arnan M; Peralta T; Clopés A; de Sevilla AF; Duarte RF
    J Med Econ; 2013; 16(6):736-43. PubMed ID: 23541251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.